| Symbol |
Name |
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
AR
|
androgen receptor
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
ATM
|
ATM serine/threonine kinase
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CNGB3
|
cyclic nucleotide gated channel beta 3
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4B
|
eukaryotic translation initiation factor 4B
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EP300
|
E1A binding protein p300
|
|
EPOR
|
erythropoietin receptor
|
|
ESR1
|
estrogen receptor 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
EZR
|
ezrin
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
GAP43
|
growth associated protein 43
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
H2AFX
|
H2A histone family, member X
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
LIMK1
|
LIM domain kinase 1
|
|
LIMK2
|
LIM domain kinase 2
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MSN
|
moesin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYL12B
|
myosin, light chain 12B, regulatory
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PFKFB2
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PXN
|
paxillin
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RB1
|
retinoblastoma 1
|
|
RDX
|
radixin
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RNF11
|
ring finger protein 11
|
|
RPLP2
|
ribosomal protein, large, P2
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SMAD2
|
SMAD family member 2
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK4
|
serine/threonine kinase 4
|
|
SYN1
|
synapsin I
|
|
SYTL1
|
synaptotagmin-like 1
|
|
TBC1D1
|
TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1
|
|
TP53
|
tumor protein p53
|
|
TP53RK
|
TP53 regulating kinase
|
|
VAV2
|
vav 2 guanine nucleotide exchange factor
|
|
VCP
|
valosin containing protein
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|